期刊文献+

RT-PCR检测肝炎和肝癌组织中的HCV复制中间体 被引量:3

DETECTION OF MINUS STRAND RNA OF HCV IN LIVER TISSUES OF PATIENT WITH HEPATITIS C AND HEPATOCELLULAR CARCINOMA BY RT-PCR
原文传递
导出
摘要 应用逆转录聚合酶链反应(RT—PCR)检测11例血清抗HCV阳性的药瘾患者尸检肝组织和10例原发性肝细胞癌(PHC)患者手术切除肝癌组织中HCV基因(正链HCV RNA)和HCV复制中间体(负链HCV RNA)。结果8/11例肝组织和7/10例肝癌组织中正链HCV RNA阳性,其中各有6例负链HCV RNA亦阳性。HCV各基因区的检出率差别较大,5′NC区检出率最高、C区次之、NS区检出率较低。在同例肝(癌)组织中,若负链HCV RNA阳性,则其信号强度与正链基因无明显差别;但未发现肝癌组织中癌细胞分化程度与HCV的检出率有关。上述结果提示HCV感染与肝癌发生有密切关系,HCV的持续复制可能在癌肿形成中起作用。 11 cases of drug addicts with their serum anti-HCV positive and 10 cases of hepatocellular carcinoma were examined for HCV genes (plus strand RNA) and HCV middle replicated forms (minus strand RNA)in their liver tissues by reverse-transcription polymerase chain reaction(RT-PCR). The results showed plus HCV-RNA in the liver tissues of 8/11 cases and the cancer tissues of 7/1 0 cases were positive .minus strand HCV RNA of 6 cases in each group were positive. The positive rate of each region of HCV gene was much more different ,that of 5NC-region was the most. NS-region was the lowest. In the cancer tissues of a same case,if minus strand RNA of HCV was positive,its signal intension had no significant difference from that of HCV plus strand RNA. But the degree of differentiation of the cancer cells in the tissues of hepatocellular carcinoma was not found to be associated with the positive rate of HCV. The results above indicated that HCV infection were colsely associated with the incidence of hepatocellular carcinoma,and the constant replication of HCV might play a role in formating liver tumor.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 1995年第2期116-119,共4页 Chinese Journal of Microbiology and Immunology
关键词 丙型肝炎病毒 复制中间体 聚合酶链反应 肝肿瘤 Hepatitis C virus Minus strand RNA Hepatocellular carcinoma Polymerase chain reaction
  • 相关文献

参考文献1

  • 1Cheng Qian,Hepatology,1992年,16卷,380页

同被引文献18

  • 1张东华,金根娣,陈竺,陆志檬.套式聚合酶链反应检测丙肝病毒核酸[J].上海第二医科大学学报,1994,14(3):195-198. 被引量:3
  • 2刘勇,陈智,刘克洲,何南祥,章明太,王信子.重组丙型肝炎病毒基因转染H9细胞模型的建立[J].中华肝脏病杂志,1997,5(2):103-105. 被引量:1
  • 3[1]Kakizaki S, Takagi H, Horiguchi N, et al. Iron enhances hepatitis C virus replication in cultured human hepatocytes[J]. Liver, 2000, 20(2): 125-128.
  • 4[2]Mizutani T, Kato N, Ikeda M, et al. Long-term human Tcell culture system supporting hepatitis C virus replication [J]. Biochem Biophys Res Commun, 1996, 227(3): 822-826.
  • 5[3]Garson JA, Lubach D, Passas J, et al. Suramin blocks hepatitis C binding to human hepatoma cells in vitro[J]. J Med Virol, 1999, 57(3): 238-242.
  • 6[4]Seipp S, Mueller HM, Pfaff E, et al. Establishment of persistent hepatitis C virus infection and replication in vitro [J]. J Gen Virol, 1997, 78(pt 10): 2467-2476.
  • 7[5]Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources[J]. J Gen Virol, 1992, 73(pt 3): 673-679.
  • 8[8]Bchini R, Capel F, Dauguet C,et al. In vitro infection of human hepatoma(HepG2) cells with hepatitis B virus[J]. J Virol, 1990, 64(6): 3025-3032.
  • 9[9]Tagawa M, Kato N, Yokosuka O, et al. Infection of human hepatocyte cell lines with hepatitis C virus in vitro [J],J Gastroenterol. Hepatol, 1995, 10(5): 523-527.
  • 10[10]Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81[J]. Science, 1998, 282(5390):938-941.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部